NULYTELY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nulytely, and when can generic versions of Nulytely launch?
Nulytely is a drug marketed by Braintree and is included in one NDA.
The generic ingredient in NULYTELY is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are four hundred and twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NULYTELY?
- What are the global sales for NULYTELY?
- What is Average Wholesale Price for NULYTELY?
Summary for NULYTELY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 168 |
Clinical Trials: | 9 |
Drug Prices: | Drug price information for NULYTELY |
What excipients (inactive ingredients) are in NULYTELY? | NULYTELY excipients list |
DailyMed Link: | NULYTELY at DailyMed |
Recent Clinical Trials for NULYTELY
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gastroenterology Services, Ltd. | |
ColonaryConcepts LLC | Phase 2 |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 3 |
US Patents and Regulatory Information for NULYTELY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Braintree | NULYTELY | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION;ORAL | 019797-001 | Apr 22, 1991 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Braintree | NULYTELY-FLAVORED | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION;ORAL | 019797-002 | Nov 18, 1994 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |